89.71
[1]. Anna M Urban, et al. Formation and repair of pyridyloxobutyl DNA adducts and their relationship to tumor yield in A/J mice. Chem Res Toxicol. 01 Oct 1;(10):167-78.
[]. George C Bobustuc, et al. MGMT inhibition restores ERα functional sensitivity to antiestrogen therapy. Mol Med. 01 Sep 7;18(1):91-9.
[]. Holly J Meany, et al. Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors. Cancer Chemother Pharmacol. 009 Dec;6(1):17-4.
[4]. Narin Apisarnthanarax, et al. Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type. Arch Dermatol. 01 May;148():61-0.
[]. Rui Zhu, et al. 4-nitrobenzyloxycarbonyl derivatives of O(6)-benzylguanine as hypoxia-activated prodrug inhibitors of O(6)-alkylguanine-DNA alkyltransferase (AGT), which produces resistance to agents targeting the O-6 position of DNA guanine. J Med Chem. 011 Nov 10;4(1):770-8.
H1-H19-H
P61-P64-P71-P80-P0+P-P04+P40-P6+P64-P40-P01